AFLD 2014 FFC vs Respondent M11

Facts
The French Cycling Federation (Fédération Française de Cyclisme, FFC) charges respondent M11 for a violation of the Anti-Doping Rules. During a cycling event on September 1, 2013, respondent provided a sample for doping test purposes. Analysis of the sample showed the presence of salmeterol which is a prohibited substance according the World Anti-Doping Agency (WADA) prohibited list. It is regarded as a specified substance.

History
The respondent used medication containing salmeterol, he did mention the use on the doping control form. He uses two puffs a day to treat chronic rhinitis and asthma. He has a certificate from his physician, a pulmonary examination and blood tests to prove his condition.
The panel regards the documents and the concentration measured as medical justifiable for the use of the medication.

Decision
1. The respondent is acquitted.
2. The decision will be published and sent to the parties involved.

Original document

Parameters

Legal Source
National Decisions
Date
19 February 2014
Original Source
French Anti-Doping Agency (AFLD)
Country
France
Language
French
ADRV
Adverse Analytical Finding / presence
Legal Terms
Acquittal
Sport/IFs
Cycling (UCI) - International Cycling Union
Other organisations
Agence Française de Lutte contre le Dopage (AFLD) - French Anti-Doping Agency
Fédération Française de Cyclisme (FFC) - French Cycling Federation
Laboratories
Paris, France: Agence Française de Lutte contre le Dopage (AFLD)
Doping classes
S3. Beta-2 Agonists
Substances
Salmeterol
Medical terms
Legitimate Medical Treatment
Document type
Pdf file
Date generated
8 August 2014
Date of last modification
5 September 2014
Category
  • Legal Source
  • Education
  • Science
  • Statistics
  • History
Country & language
  • Country
  • Language
Other filters
  • ADRV
  • Legal Terms
  • Sport/IFs
  • Other organisations
  • Laboratories
  • Analytical aspects
  • Doping classes
  • Substances
  • Medical terms
  • Various
  • Version
  • Document category
  • Document type
Publication period
Origin